IMVACC: a Master of Advanced Studies (MAS) in vaccinology

The University of Lausanne (UNIL) is offering an International Master in Vaccinology (IMVACC) developed by the Swiss Vaccine Research Institute (SVRI) and the Health Sciences e-Training Foundation (HSeT) in collaboration with the Lausanne University Hospital (CHUV).

IMVACC comprises one year of on-line teaching of vaccinology followed by a 6 months to one year specialization internship in a vaccine-related activity (industry, basic or translational research, regulatory affairs, etc.) including the preparation of a master's thesis. Graduates will gain a broad knowledge of how vaccines are designed, developed, manufactured and implemented through public health programs.

To develop the vaccines of the future

Scientists, physicians, and engineers with a broad knowledge in vaccines are needed to respond to the threats of emerging diseases and to continue the development of vaccines against tuberculosis, enteric infections, AIDS and malaria. Existing vaccines also need to be updated to take advantage of the progress in manufacturing and quality control technologies. IMVACC students will acquire a broad knowledge of how vaccines are designed, developed, manufactured and implemented through public health programs.  

To develop a network of vaccinologists

To contribute more efficiently to the development of vaccines, IMVACC students will be provided with the opportunity to work on real-life questions and situations encountered in vaccine development and to develop their professional network. They will gain broad scientific, strategic and technical experience applicable to their work environment. Vaccine experts are also needed to help counter the rising skepticism of people regarding the safety and efficacy of vaccines.

For professionals in medical sciences

IMVACC has been designed for a broad population of medical science professionals who are actively engaged in a professional work environment and who want to broaden and deepen their knowledge of vaccines.

Tutor-assisted on-line teaching

The flexible on-line teaching approach accommodates the time constraints of the trainees and saves long-distance travel and housing expenses. It also allows the students to engage in individual and group activities with the support of tutors. These features set IMVACC apart from existing vaccinology courses.

Click here to obtain the IMVACC brochure.

 

If you are interested in IMVACC and you want to know
the tuition and fees of this MAS, please contact the program administrator Davide Mercuri.

 

 

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.

HON Search

Last update: Saturday, April 29, 2017
Contact
© Creative Commons

News

  • The kickoff meeting for the class 2016 of IMVACC took place on September 5 to 7, 2016 in Lausanne, Switzerland (Program).


The Swiss Vaccine Research Center, the Research laboratories of the Service of Immunology & Allergy (IAL) of the University Hospital (CHUV), and the Health Sciences eTraining Foundation (HSeT), are located in Epalinges near Lausanne in Switzerland.

“With its on-line, tutor-supported teaching approach, IMVACC offers a new way to train students in vaccinology across the World. It fits well with the goal of WHO to build capacity for science and research, especially in low- and middle-income countries.”

Dr Marie-Paule Kieny, Assistant Director-General, WHO, Geneva

Partners

X
Searching definition